As described by a study by Ramsey et al, use of CFTR modulators has been shown to be effective at reducing and delaying incidence and progression of CF cirrhosis patients in combination with ursodiol therapy compared to those receiving ursodiol alone.18 This evidence concerns the gene CFTR and cystic fibrosis.